# Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19

> **NCT04376788** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 15 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** exchange blood transfusion from normal donor
- **BIOLOGICAL:** plasma from convalescent patients with COVID-19
- **DRUG:** Methylene Blue 5 MG/ML

## Key facts

- **NCT ID:** NCT04376788
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-20
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04376788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04376788, "Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04376788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*